The table below shows Atara Biotherapeutics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$3.07M
-$28.14M
-$29.61M
-$38.43M
-$84.53M
-$65.70M
Capital expenditure
-
$0.00
$127.00K
$399.00K
$2.60M
$2.20M
Investing cash flow
$0.00
$17.20M
$14.72M
-$6.01M
$60.22M
$13.50M
Dividends paid
-
-
-
-
ATRA operating cash flow (10-K history)
Atara Biotherapeutics, Inc. reported operating cash flow of -$50.94M for fiscal year 2025. That is up 25.9% from -$68.72M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$60.02M (FY 2016) to -$50.94M. Figures come from the company's audited annual reports as filed with the SEC.